A Cost Comparison of Oral Tegafur Plus Uracil/Folinic Acid and Parenteral Fluorouracil for Colorectal Cancer in Canada

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.21, Iss.14, 2003-01, pp. : 1039-1051

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral tegafur/uracil + folinic acid in colorectal cancer

Inpharma, Vol. 1, Iss. 1538, 2006-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Costs Incurred by Patients Undergoing Advanced Colorectal Cancer Therapy: A Comparison of Raltitrexed and Fluorouracil plus Folinic Acid

By Sculpher M.

PharmacoEconomics, Vol. 17, Iss. 4, 2000-04 ,pp. : 361-370

Adis International

Access to resources Recommend Favorite

Tegafur/uracil less costly than fluorouracil in colorectal cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 431, 2003-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Tegafur/uracil less costly than fluorouracil in colorectal cancer

Inpharma, Vol. 1, Iss. 1406, 2003-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Irinotecan plus fluorouracil and folinic acid should be the comparator regimen in clinical trials involving patients with metastatic colorectal cancer

Inpharma, Vol. 1, Iss. 1232, 2000-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite